These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 2541177
21. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned? Erman A, Boner G, van Dijk DJ. J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):365-8. PubMed ID: 11967825 [Abstract] [Full Text] [Related]
22. Effects of captopril once daily on blood pressure and angiotensin converting enzyme in hypertensive patients. Rodriguez FJ, Gil V, del Carmen Beneyto M, Lopez-Vidriero E. Postgrad Med J; 1986 Dec; 62 Suppl 1():94-6. PubMed ID: 2825151 [Abstract] [Full Text] [Related]
23. ACE inhibitors captopril and enalapril induce regression of left ventricular hypertrophy in hypertensive patients with chronic renal failure. Dyadyk AI, Bagriy AE, Lebed IA, Yarovaya NF, Schukina EV, Taradin GG. Nephrol Dial Transplant; 1997 May; 12(5):945-51. PubMed ID: 9175047 [Abstract] [Full Text] [Related]
24. Angiotensin converting enzyme inhibitors. Disparities in the mechanism of their antihypertensive effect. Garavaglia GE, Messerli FH, Nunez BD, Schmieder RE, Frohlich ED. Am J Hypertens; 1988 Jul; 1(3 Pt 3):214S-216S. PubMed ID: 2843195 [Abstract] [Full Text] [Related]
25. Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice. de Nigris F, D'Armiento FP, Somma P, Casini A, Andreini I, Sarlo F, Mansueto G, De Rosa G, Bonaduce D, Condorelli M, Napoli C. Int J Cardiol; 2001 Dec; 81(2-3):107-15; discusssion 115-6. PubMed ID: 11744122 [Abstract] [Full Text] [Related]
30. Humoral and hemodynamic effects of increasing doses of captopril in patients with essential hypertension. Sassano P, Pedrinelli R, Magagna A, Abdel-Haq B, Salvetti A. Am J Cardiol; 1982 Apr 21; 49(6):1574-6. PubMed ID: 6280486 [Abstract] [Full Text] [Related]
31. Captopril versus enalapril: a comparison of 24 h humoral and hypotensive effects. Cottone S, Grasso L, D'Ignoto G, Contorno A, Ziletti T, Carapelle E, Carone MB, Fulantelli MA, Cerasola G. Boll Soc Ital Biol Sper; 1987 Sep 30; 63(9):803-10. PubMed ID: 2833914 [No Abstract] [Full Text] [Related]
32. Comparison of enalapril to captopril by 24-hour ambulatory blood pressure monitoring. Bental T, Lishner M, Lalkin A, Elis A, Ravid M. J Clin Pharmacol; 1997 Jun 30; 37(6):514-9. PubMed ID: 9208358 [Abstract] [Full Text] [Related]
33. Effect of captopril (SQ 14225) on blood pressure, plasma renin activity and angiotensin I converting enzyme activity. Larochelle P, Genest J, Kuchel O, Boucher R, Gutkowska Y, McKinstry D. Can Med Assoc J; 1979 Aug 04; 121(3):309-16. PubMed ID: 223756 [Abstract] [Full Text] [Related]
37. Acute dose-response curve of enalapril in renovascular hypertensives. Arzilli F, Magagna A, Giovannetti R, Nuccorini A, Salvetti A. Am J Hypertens; 1988 Jul 04; 1(3 Pt 3):75S-78S. PubMed ID: 2843201 [Abstract] [Full Text] [Related]
38. Quality of life and antihypertensive therapy in men. A comparison of captopril with enalapril. The Quality-of-Life Hypertension Study Group. Testa MA, Anderson RB, Nackley JF, Hollenberg NK. N Engl J Med; 1993 Apr 01; 328(13):907-13. PubMed ID: 8446137 [Abstract] [Full Text] [Related]
39. [Evaluation of captopril-enalapril replacement therapy in hypertensive patients under ambulatory blood pressure monitoring]. Ruszty L, Hidas I, Iványi J, Dudás M, Molnár S. Orv Hetil; 1996 Dec 22; 137(51):2851-4. PubMed ID: 9679620 [Abstract] [Full Text] [Related]